tiprankstipranks
Trending News
More News >
Faes Farma (ES:FAE)
:FAE

Faes Farma (FAE) Price & Analysis

Compare
13 Followers

FAE Stock Chart & Stats


---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.47%4.46%94.04%
4.46%
Mutual Funds
― Other Institutional Investors
94.04% Public Companies and
Individual Investors

FAE FAQ

What was Faes Farma’s price range in the past 12 months?
Faes Farma lowest stock price was €3.27 and its highest was €4.37 in the past 12 months.
    What is Faes Farma’s market cap?
    Faes Farma’s market cap is €1.33B.
      When is Faes Farma’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Faes Farma’s earnings last quarter?
      Faes Farma released its earnings results on Oct 31, 2024. The company reported €0.188 earnings per share for the quarter, beating the consensus estimate of N/A by €0.188.
        Is Faes Farma overvalued?
        According to Wall Street analysts Faes Farma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Faes Farma pay dividends?
          Faes Farma pays a Annually dividend of €0.126 which represents an annual dividend yield of 2.96%. See more information on Faes Farma dividends here
            What is Faes Farma’s EPS estimate?
            Faes Farma’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Faes Farma have?
            Faes Farma has 316,223,940 shares outstanding.
              What happened to Faes Farma’s price movement after its last earnings report?
              Faes Farma reported an EPS of €0.188 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.573%.
                Which hedge fund is a major shareholder of Faes Farma?
                Currently, no hedge funds are holding shares in ES:FAE
                ---

                Faes Farma Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                24.94%
                12-Months-Change

                Fundamentals

                Return on Equity
                16.04%
                Trailing 12-Months
                Asset Growth
                9.93%
                Trailing 12-Months

                Company Description

                Faes Farma

                Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Almirall
                Bankinter
                Clinica Baviera
                Grifols
                Laboratorios Farmaceuticos Rovi
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis